Evolva (EVE)

Business description

Evolva is a Swiss high-tech fermentation company. It has a proprietary yeast technology platform, which it uses to create and manufacture high-value speciality molecules for nutritional and consumer products.

Stock data

Market cap.CHF178.2m
Last closeCHF0.42
High / Low (52 weeks)CHF0.8 / CHF0.4
Stock market listingSW
Forecast net cash (CHFm)33.2
Forecast gearing ratio (%)N/A
TeamConsumer
SectorFood & Drink

Price performance

%1m3m12m
Actual(10.6)(20.8)(43.2)
Relative *(10.4)(19.9)(47.7)

* % Relative to local index

Other companies in sector Show

Company news

0.4637

Fri, 22 Nov 2013 11:19:43 GMT

Evolva Holding SA (SWX:EVE): Honing in on the Technicals

Wed, 16 Aug 2017 00:58:27 GMT

Watching the Tape Move for Evolva Holding SA (ELVAF)

Tue, 15 Aug 2017 03:11:15 GMT

Evolva & Cargill Announce Publication Of Stevia Reb M Patent Application

Fri, 15 Aug 2014 05:01:33 GMT

Evolva to Acquire Allylix

Tue, 18 Nov 2014 06:01:29 GMT

Y/E Dec Revenue (CHFm) EBITDA (CHFm) PBT (CHFm) EPS (CHF) P/E (x) P/CF (x)
2015A 13.4 (30.3) (32.1) (8.0) N/A N/A
2016A 9.6 (34.0) (35.9) (7.8) N/A N/A
2017E 15.3 (23.5) (24.6) (6.0) N/A N/A
2018E 23.3 (20.4) (21.0) (5.0) N/A N/A

Last updated on 19/07/2017

Latest research

Agreement reached

Outlook | Food & Drink | 09/05/2017

Headroom improves

Update | Food & Drink | 16/03/2017

A cloudier picture

Update | Food & Drink | 16/01/2017

On track

Update | Food & Drink | 01/09/2016

Positive stevia newsflow

Update | Food & Drink | 07/06/2016

Stevia delayed

Update | Food & Drink | 06/04/2016

Tastes good

Outlook | Food & Drink | 15/01/2016

Getting sweeter

QuickView | Food & Drink | 19/11/2015

Rights issue supports stevia JV

Update | Food & Drink | 07/09/2015

Manufacturing a sweeter future

Update | Pharmaceutical & healthcare | 18/05/2015

Daily comment

Institutional Comment | Pharmaceutical & healthcare | 11/02/2015

Gaining dominance

Update | Pharmaceutical & healthcare | 11/02/2015

Investment summary

Evolva has an innovative fermentation platform focused on developing new production methods for nutritional and consumer health products, which removes supply chain issues for existing natural ingredients. Evolva's key programme for stevia sweeteners is partnered with Cargill and we continue to expect launch during 2018. Evolva also has projects for resveratrol, nootkatone, valencene (all on the market). Evolva expects to invest CHF60m in new fermentation and bioprocessing facilities. Management expects to secure additional project financing of c CHF30m by the end of 2017. Simon Waddington (previously COO) has recently taken over as CEO from Neil Goldsmith to lead Evolva into the next phase of growth.

Last updated on 03/08/2017

Industry outlook

Food and health ingredients continue to be in the sweet spot as consumers demand healthier products with cleaner labels without compromising on taste or convenience. Evolva's fermentation platform aims to deliver these benefits while reducing production costs.

Last updated on 03/08/2017

Key management

Gerard Hoetmer, Chairman
Simon Waddington, CEO
Oliver Walker, CFO

Company address

Duggingerstrasse. 23
Reinach
CH-4153
Switzerland
+41 61 485 2000
View website